| Literature DB >> 20861378 |
Inga U Schapitz1, Bardo Behrend, Yvonne Pechmann, Corinna Lappe-Siefke, Silas J Kneussel, Karen E Wallace, A Vanessa Stempel, Fritz Buck, Seth G N Grant, Michaela Schweizer, Dietmar Schmitz, Jürgen R Schwarz, Erika L F Holzbaur, Matthias Kneussel.
Abstract
Neuroligins are postsynaptic cell adhesion molecules that associate with presynaptic neurexins. Both factors form a transsynaptic connection, mediate signaling across the synapse, specify synaptic functions, and play a role in synapse formation. Neuroligin dysfunction impairs synaptic transmission, disrupts neuronal networks, and is thought to participate in cognitive diseases. Here we report that chemical treatment designed to induce long-term potentiation or long-term depression (LTD) induces neuroligin 1/3 turnover, leading to either increased or decreased surface membrane protein levels, respectively. Despite its structural role at a crucial transsynaptic position, GFP-neuroligin 1 leaves synapses in hippocampal neurons over time with chemical LTD-induced neuroligin internalization depending on an intact microtubule cytoskeleton. Accordingly, neuroligin 1 and its binding partner postsynaptic density protein-95 (PSD-95) associate with components of the dynein motor complex and undergo retrograde cotransport with a dynein subunit. Transgenic depletion of dynein function in mice causes postsynaptic NLG1/3 and PSD-95 enrichment. In parallel, PSD lengths and spine head sizes are significantly increased, a phenotype similar to that observed upon transgenic overexpression of NLG1 (Dahlhaus et al., 2010). Moreover, application of a competitive PSD-95 peptide and neuroligin 1 C-terminal mutagenesis each specifically alter neuroligin 1 surface membrane expression and interfere with its internalization. Our data suggest the concept that synaptic plasticity regulates neuroligin turnover through active cytoskeleton transport.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20861378 PMCID: PMC3108891 DOI: 10.1523/JNEUROSCI.0896-10.2010
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167